Fig. 2From: Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKitBox plots of biomarkers by disease stage and amyloid-β status as defined by Aβ42/Aβ40 ratio; A uncorrected values and B corrected values. Aβ40, amyloid-β1–40; Aβ42, amyloid-β1–42; AD, Alzheimer’s disease; CU, cognitively unimpaired; MCI, mild cognitive impairment; pTau, phosphorylated tauBack to article page